In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

See also:

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. October 05, 2021

    CVS, Walmart Opioid Trial Defense Hazy On Pharmacists' Role

    Jurors in the first trial over pharmacies' alleged role in fueling the opioid crisis heard seemingly contradictory opening statements on Tuesday from CVS and Walmart, whose attorneys alternately claimed the chains have almost no control over what's dispensed but also maintain independent discretion.

  2. October 04, 2021

    Pharmacies' Opioid Screening 'Totally Ineffective,' Jury Hears

    The first trial against pharmacies over their alleged roles in the opioid crisis began Monday in Cleveland with a federal jury hearing claims that Walgreens and others' systems to catch illegitimate prescriptions were riddled with holes.

  3. October 01, 2021

    Counties Say Opioid Trial Can Redress 'Great Stress' Of Crisis

    The two Ohio counties set to battle national pharmacies starting Monday in a key opioid bellwether have strong steel and manufacturing roots and see the trial as their chance to hold companies accountable for the extreme financial stress the crisis has brought to their already struggling communities.

  4. September 30, 2021

    Cherokee Want Pharmacies In State Court After Opioid Deal

    The Cherokee Nation asked an Oklahoma federal judge to remand opioid-related claims against pharmacy companies, including CVS and Walgreens, to state court, arguing there is no longer federal jurisdiction after settling with McKesson, AmerisourceBergen and Cardinal Health earlier this week.

  5. September 29, 2021

    7 Key Details As Pharmacy Giants Head To 1st Opioid Trial

    After years of bobbing and weaving, pharmacy titans CVS, Walgreens and Walmart are poised to go toe-to-toe with heavyweight plaintiffs lawyers in the first opioid trial targeting the pharmacy sector. Here, Law360 looks at the showdown's lead lawyers, biggest uncertainties and intensely acrimonious atmosphere.

  6. September 28, 2021

    Cherokee Nation Inks $75M Opioid Deal With Distributors

    The Cherokee Nation announced Tuesday that it's reached a $75 million settlement with AmerisourceBergen Corp., Cardinal Health Inc. and McKesson Corp. over claims that the companies contributed to the opioid epidemic.

  7. September 21, 2021

    Ohio Counties Want Unvaxxed Jurors Out Of Opioid MDL Trial

    Two Ohio counties involved in an upcoming bellwether trial against pharmacies in sprawling multidistrict opioid litigation asked an Ohio federal judge on Tuesday to exclude nearly 40 potential jurors who are not vaccinated against COVID-19, saying that allowing unvaccinated jurors to serve on the jury would be likely to disrupt the trial.

  8. September 20, 2021

    Judge Limits Stanford Doctor's Testimony In Opioid MDL

    An Ohio federal judge narrowed what a Stanford University doctor will be allowed to testify about when it comes to aspects of opioid pharmacy operations during an upcoming bellwether trial, but she will allow the expert to speak on alleged "red flags" the industry ignored.

  9. September 17, 2021

    Endo's Attys In 'Career-Wrecking' Peril As Opioid Woes Grow

    A flash flood of misconduct inquiries in opioid litigation across the country is rapidly engulfing Endo Pharmaceuticals and threatening to inflict considerable damage on the professional reputations of its Arnold & Porter attorneys, according to legal filings, court proceedings and interviews.

  10. September 14, 2021

    'Red Flag' Expert's Opinion Limited In Opioid MDL

    An Ohio federal judge will limit the scope of an expert's testimony about how pharmacies failed to heed "red flags" meant to curb the diversion of opioids, saying he can opine that the alleged failure likely led to the drugs getting out on the streets, but he cannot establish a direct causal link.